Table 2.
Clinical Features | Study Group | Control Group | p-Value |
---|---|---|---|
pd | 8 (72.7%) | 18 (43.7%) | <0.05 |
et | 3 (27.3%) | 23 (56.3%) | |
Age (Years) |
61.8 ± 9.26 (47–74) |
67.1 ± 10.49 (48–85) |
0.144 |
Gender | 3 F; 8 M | 10 F; 31 M | 0.84 |
Disease Duration (Years) | 9.9 ± 5.57 (3–19) |
16.94 ± 8.53 (2–31) |
0.022 |
sdr | 0.48 ± 0.06 (0.35–0.57) |
0.43 ± 0.09 (0.27–0.57) |
0.001 |